Emily Nash Smyth
- Oncology top 10%
- Cancer-related Molecular Pathways 5
- Lung Cancer Research Studies 5
- Cancer Treatment and Pharmacology 4
- Cancer survivorship and care 4
-
- Advanced Breast Cancer Therapies 15
- Lung Cancer Treatments and Mutations 7
-
- Cancer Genomics and Diagnostics 5
-
- Chronic Lymphocytic Leukemia Research 4
Emily Nash Smyth
41 papers receiving 487 citations
Peers
Comparison fields: 5 of 77
- Oncology 267
- Pulmonary and Respiratory Medicine 172
- Sensory Systems 24
- Cancer Research 63
- Genetics 40
Countries citing papers authored by Emily Nash Smyth
This map shows the geographic impact of Emily Nash Smyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Nash Smyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Nash Smyth more than expected).
Fields of papers citing papers by Emily Nash Smyth
This network shows the impact of papers produced by Emily Nash Smyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Nash Smyth. The network helps show where Emily Nash Smyth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily Nash Smyth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 10 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 12 | |
| 11 | 2020 | 7 | |
| 12 | 2019 | 10 | |
| 13 | 2018 | 51 | |
| 14 | 2016 | 29 | |
| 15 | 2015 | 1 | |
| 16 | 2015 | 13 | |
| 17 | 2015 | 23 | |
| 18 | 2014 | 28 | |
| 19 | 2013 | 19 | |
| 20 | 2010 | 15 |
About Emily Nash Smyth
Emily Nash Smyth is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 42 papers that have together received 496 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (15 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer-related Molecular Pathways (5 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Research Studies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer survivorship and care (4 papers). The work is most often cited by research in Oncology (267 citations), Pulmonary and Respiratory Medicine (172 citations) and Sensory Systems (24 citations). Emily Nash Smyth has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Lee Bowman, Steven L. Batki, Lee Bowman, Paweł J. Matusz, Trudi Edginton, Micah M. Murray, Alison F. Eardley, Gregory L. Price, James A. Kaye and Daniel Ball. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.